Gender differences in osteoporosis and fractures
- PMID: 21264553
- PMCID: PMC3111766
- DOI: 10.1007/s11999-011-1780-7
Gender differences in osteoporosis and fractures
Abstract
Background: Osteoporosis is generally thought of as a "woman's disease" because the prevalence of osteoporosis and the rate of fractures are much higher in postmenopausal women than in older men. However, the absolute number of men affected by osteoporosis and fractures is large, as at least 2.8 million men in the United States are thought to have osteoporosis.
Questions/purposes: The purposes of this review are to (1) highlight gender differences in osteoporosis and fracture risk, (2) describe disparities in treatment and outcomes after fractures between men and women, and (3) propose solutions to reducing disparities in treatment and prevention.
Methods: A literature survey was conducted using MEDLINE with a variety of search terms and using references from the author's personal collection of articles. A formal search strategy and exclusion criteria were not employed and the review is therefore selective. WHERE ARE WE NOW?: Postmenopausal women have a higher prevalence of osteoporosis and greater incidence of fracture than older men. Despite the higher fracture risk in postmenopausal women, older men tend to have worse outcomes after fracture and poorer treatment rates, although less is known about the disease course in men. Multifaceted interventions to improve the screening and treatment for osteoporosis were recently developed. WHERE DO WE NEED TO GO?: Improvement in treatment rates of those at risk, regardless of gender, is an important goal in osteoporosis management. HOW DO WE GET THERE?: Further development and evaluation of cost-effective, multifaceted interventions for screening and treatment of osteoporosis and fractures are needed; such interventions will likely improve the primary prevention of fractures.
Similar articles
-
Sex and gender considerations in male patients with osteoporosis.Clin Orthop Relat Res. 2011 Jul;469(7):1906-12. doi: 10.1007/s11999-011-1849-3. Clin Orthop Relat Res. 2011. PMID: 21400003 Free PMC article. Review.
-
Defining ethnic and racial differences in osteoporosis and fragility fractures.Clin Orthop Relat Res. 2011 Jul;469(7):1891-9. doi: 10.1007/s11999-011-1863-5. Clin Orthop Relat Res. 2011. PMID: 21431462 Free PMC article. Review.
-
Fracture prevention in men.Nat Rev Rheumatol. 2009 Sep;5(9):497-504. doi: 10.1038/nrrheum.2009.148. Epub 2009 Jul 28. Nat Rev Rheumatol. 2009. PMID: 19636335 Review.
-
Osteoporosis: an invisible, undertreated, and neglected disease of elderly men.J Elder Abuse Negl. 2007;19(1-2):61-73, table of contents. doi: 10.1300/J084v19n01_05. J Elder Abuse Negl. 2007. PMID: 18077270 Review.
-
Minimizing disparities in osteoporosis care of minorities with an electronic medical record care plan.Clin Orthop Relat Res. 2011 Jul;469(7):1931-5. doi: 10.1007/s11999-011-1852-8. Clin Orthop Relat Res. 2011. PMID: 21424836 Free PMC article.
Cited by
-
Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas.Sarcoma. 2021 Mar 15;2021:8877567. doi: 10.1155/2021/8877567. eCollection 2021. Sarcoma. 2021. PMID: 33790687 Free PMC article. Review.
-
Estrogen and estrogen receptors mediate the mechanobiology of bone disease and repair.Bone. 2024 Nov;188:117220. doi: 10.1016/j.bone.2024.117220. Epub 2024 Aug 5. Bone. 2024. PMID: 39106937 Review.
-
Association Between Bipolar Disorder and Low Bone Mass: A Cross-Sectional Study With Newly Diagnosed, Drug-Naïve Patients.Front Psychiatry. 2020 Jun 10;11:530. doi: 10.3389/fpsyt.2020.00530. eCollection 2020. Front Psychiatry. 2020. PMID: 32587534 Free PMC article.
-
Circulating Long Non-Coding RNA GAS5 Is Overexpressed in Serum from Osteoporotic Patients and Is Associated with Increased Risk of Bone Fragility.Int J Mol Sci. 2020 Sep 21;21(18):6930. doi: 10.3390/ijms21186930. Int J Mol Sci. 2020. PMID: 32967315 Free PMC article. Clinical Trial.
-
Prevalence and treatment of fragility fractures in Spanish primary care: PREFRAOS study.Arch Osteoporos. 2022 Jul 15;17(1):93. doi: 10.1007/s11657-022-01124-7. Arch Osteoporos. 2022. PMID: 35836031 Free PMC article.
References
-
- Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008;11:75–91. doi: 10.1016/j.jocd.2007.12.007. - DOI - PubMed
-
- Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809–1822. doi: 10.1056/NEJMoa067312. - DOI - PubMed
-
- Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077–2082. doi: 10.1001/jama.280.24.2077. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical